CDC awards grant to controversial Danish researchers with ties to top FDA official
6.5
来源：
STAT
发布时间：
2025-12-18 20:00
摘要：
CDC has awarded a $1.6 million grant for a controversial study on hepatitis B vaccines in newborns, led by researchers from the University of Southern Denmark. The study aims to assess the impact of administering the vaccine at birth versus the current standard of care in Guinea-Bissau. However, ethical concerns have been raised regarding the study's design and its applicability to U.S. vaccine policy, as the benefits of the vaccine may not be evident until decades later.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+
business_impact
0.0分+
scientific_rigor
1.0分+
timeliness_innovation
1.0分+
investment_perspective
2.5分+
market_value_relevance
0.5分+
team_institution_background
0.5分+
technical_barrier_competition
1.0分+
关键证据
CDC awarded a $1.6 million grant for a study on hepatitis B vaccines.
The study design has raised ethical concerns regarding vaccine administration.
Critics argue that the study's findings may not be applicable to high-income countries.
真实性检查
否
AI评分总结
CDC has awarded a $1.6 million grant for a controversial study on hepatitis B vaccines in newborns, led by researchers from the University of Southern Denmark. The study aims to assess the impact of administering the vaccine at birth versus the current standard of care in Guinea-Bissau. However, ethical concerns have been raised regarding the study's design and its applicability to U.S. vaccine policy, as the benefits of the vaccine may not be evident until decades later.